Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton’s Jelly-derived Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are a useful source for cell-based therapy of a variety of immune-mediated diseases, including neurodegenerative disorders. However, poor migration ability and survival rate of MSCs after brain transplantation hinder the therapeutic effects in the disease microenvironme...
Main Authors: | Na-Hee Lee, Su Hyeon Myeong, Hyo Jin Son, Jung Won Hwang, Na Kyung Lee, Jong Wook Chang, Duk L. Na |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/19/7013 |
Similar Items
-
Persistency of Mesenchymal Stromal/Stem Cells in Lungs
by: Erica Ferrini, et al.
Published: (2021-07-01) -
Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
by: Xiaomo Wu, et al.
Published: (2020-08-01) -
Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease
by: Joseph P. McGuirk, et al.
Published: (2015-04-01) -
Circulating mesenchymal stem cells and their clinical implications
by: Liangliang Xu, et al.
Published: (2014-01-01) -
Wharton’s Jelly Mesenchymal Stem Cells: Differentiation Capacity Showing its Role in Bone Tissue Engineering
by: Rizal Rizal, et al.
Published: (2020-11-01)